InsiderClue
← All stocks

Travere Therapeutics, Inc.

TVTX Mostly scheduled
CIK 0001438533 #1223 in the set updated 22 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$104.49M
$10.46M on a plan · $92.52M straight out of an exercise
Sold at will
$1.51M
8 of 122 sales
Net
−$104.49M
−$1.51M against sales at will

By person

16 insiders · 122 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Dube Eric M
CHIEF EXECUTIVE OFFICER
—
$41.35M (21) scheduled
−$41.35M
432,886
0.4592%
$28.12M
+19.6%
Heerma Peter
EVP, CHIEF COMMERCIAL OFFICER
—
$18.97M (13) scheduled
−$18.97M
117,066
0.1242%
$7.60M
+7.1%
ROTE WILLIAM E.
Chief Research Officer
—
$16.43M (10) scheduled
−$16.43M
98,197
0.1042%
$6.38M
+12.8%
REED ELIZABETH E
Chief Legal Officer and GC
—
$7.27M (20) scheduled
−$7.27M
105,389
0.1118%
$6.85M
+31.2%
Inrig Jula
EVP, Head of R&D & CMO
—
$5.16M (15) scheduled
−$5.16M
100,491
0.1066%
$6.53M
+62.2%
Cline Christopher R.
CHIEF FINANCIAL OFFICER
—
$4.64M (15) scheduled
−$4.64M
87,508
0.0928%
$5.68M
+17.3%
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
—
$4.19M (8) scheduled
−$4.19M
42,353
0.0449%
$2.75M
−18.6%
Baynes Roy D.
Director
—
$2.55M (6) scheduled
−$2.55M
41,500
0.0440%
$2.70M
+33.9%
Meckler Jeffrey A
Director
—
$1.71M (5) scheduled
−$1.71M
91,500
0.0971%
$5.94M
+13.0%
Coughlin Timothy
Director
—
$1.27M (3) scheduled
−$1.27M
56,250
0.0597%
$3.65M
+14.8%
LYONS GARY A
Director
—
$961.41K (6) scheduled
−$961.41K
61,500
0.0652%
$3.99M
+20.6%
Squarer Ron
Director
—
—
—
39,375
0.0418%
$2.56M
+36.4%
Orwin John A
Director
—
—
—
39,375
0.0418%
$2.56M
+36.4%
Poole Sandra
Director
—
—
—
34,000
0.0361%
$2.21M
+44.7%
Bruhn Suzanne Louise
Director
—
—
—
32,750
0.0347%
$2.13M
+47.2%
Williams Brinkley Ruth
Director
—
—
—
29,750
0.0316%
$1.93M
+54.5%

Individual transactions

37
Insider
Date
Role
Action
Shares
Price
Amount
Coughlin Timothy
15 May 2026
Director
Sold on a plan
3,250
$43.49
$141.34K
Cline Christopher R.
6 May 2026
CHIEF FINANCIAL OFFICER
Sold on a plan
310
$43.95
$13.62K
Dube Eric M
6 May 2026
CHIEF EXECUTIVE OFFICER
Sold on a plan
22,500
$43.95
$988.88K
Inrig Jula
6 May 2026
CHIEF MEDICAL OFFICER
Sold on a plan
311
$43.95
$13.67K
REED ELIZABETH E
6 May 2026
Chief Legal Officer and GC
Sold on a plan
2,076
$43.95
$91.24K
ROTE WILLIAM E.
6 May 2026
Chief Research Officer
Sold on a plan
2,763
$43.95
$121.43K
Cline Christopher R.
5 May 2026
CHIEF FINANCIAL OFFICER
Sold on a plan
2,181
$46.65
$101.74K
Inrig Jula
5 May 2026
CHIEF MEDICAL OFFICER
Sold on a plan
2,174
$46.65
$101.42K
REED ELIZABETH E
5 May 2026
Chief Legal Officer and GC
Sold on a plan
2,174
$46.65
$101.42K
ROTE WILLIAM E.
22 Apr 2026
Chief Research Officer
Sold on a plan
9,100
$39.09
$355.72K
Inrig Jula
15 Apr 2026
CHIEF MEDICAL OFFICER
Sold on a plan
1,018
$42.61
$43.38K
Cline Christopher R.
15 Apr 2026
CHIEF FINANCIAL OFFICER
Sold on a plan
1,014
$42.61
$43.21K
REED ELIZABETH E
15 Apr 2026
Chief Legal Officer and GC
Sold on a plan
1,559
$42.53
$66.30K
REED ELIZABETH E
15 Apr 2026
Chief Legal Officer and GC
Sold on a plan
5,226
$41.62
$217.51K
Dube Eric M
15 Apr 2026
CHIEF EXECUTIVE OFFICER
Sold on a plan
20
$42.66
$853.20
Dube Eric M
15 Apr 2026
CHIEF EXECUTIVE OFFICER
Sold on a plan
7,165
$41.75
$299.14K
Dube Eric M
15 Apr 2026
CHIEF EXECUTIVE OFFICER
Sold on a plan
56,815
$41.01
$2.33M
Inrig Jula
14 Apr 2026
CHIEF MEDICAL OFFICER
Sold on a plan
7,215
$41.93
$302.52K
Cline Christopher R.
14 Apr 2026
CHIEF FINANCIAL OFFICER
Sold on a plan
7,239
$41.93
$303.52K
Cline Christopher R.
14 Apr 2026
CHIEF FINANCIAL OFFICER
Sold on a plan
9
$41.07
$369.63
Cline Christopher R.
13 Apr 2026
CHIEF FINANCIAL OFFICER
Sold on a plan
65
$28.85
$1.88K
REED ELIZABETH E
4 Feb 2026
Chief Legal Officer and GC
Sold on a plan
509
$32.74
$16.66K
REED ELIZABETH E
4 Feb 2026
Chief Legal Officer and GC
Sold on a plan
2,485
$32.07
$79.69K
Cline Christopher R.
4 Feb 2026
CHIEF FINANCIAL OFFICER
Sold on a plan
110
$32.90
$3.62K
Cline Christopher R.
4 Feb 2026
CHIEF FINANCIAL OFFICER
Sold on a plan
1,635
$32.14
$52.55K
Inrig Jula
4 Feb 2026
CHIEF MEDICAL OFFICER
Sold on a plan
232
$32.85
$7.62K
Inrig Jula
4 Feb 2026
CHIEF MEDICAL OFFICER
Sold on a plan
1,547
$32.11
$49.67K
ROTE WILLIAM E.
3 Feb 2026
Chief Research Officer
Sold on a plan
12,446
$32.87
$409.10K
Dube Eric M
3 Feb 2026
CHIEF EXECUTIVE OFFICER
Sold on a plan
33,635
$32.70
$1.10M
Dube Eric M
3 Feb 2026
CHIEF EXECUTIVE OFFICER
Sold on a plan
66,452
$32.06
$2.13M
Inrig Jula
6 Jan 2026
CHIEF MEDICAL OFFICER
Sold on a plan
445
$37.75
$16.80K
Inrig Jula
5 Jan 2026
CHIEF MEDICAL OFFICER
Sold on a plan
2,031
$40.18
$81.61K
Calvin Sandra
24 Dec 2025
SVP, CHIEF ACCOUNTING OFFICER
Sold on a plan
7,402
$40.00
$296.08K
Heerma Peter
24 Dec 2025
CHIEF COMMERCIAL OFFICER
Sold on a plan
4,980
$40.00
$199.20K
Calvin Sandra
15 Dec 2025
SVP, CHIEF ACCOUNTING OFFICER
Sold on a plan
2,910
$36.00
$104.76K
Heerma Peter
31 Oct 2025
CHIEF COMMERCIAL OFFICER
Sold on a plan
5,591
$35.00
$195.69K
Heerma Peter
28 Oct 2025
CHIEF COMMERCIAL OFFICER
Sold on a plan
2,662
$30.00
$79.86K
Show all 122 transactions →

What was left out

Form 4 filings counted 74
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 37
Sales straight out of an exercise 77
Sales at will 8
Transactions with no price 0
Shares from compensation/vesting 2,152,206
History held since 2 Sep 2016